Literature DB >> 15065822

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons.

B Christenson1, J Hedlund, P Lundbergh, A Ortqvist.   

Abstract

In 1999, all individuals > or = 65 yrs of age (n=258,754) in Stockholm County, Sweden, were offered influenza and pneumococcal vaccination in a prospective study on the effectiveness of these vaccines in reducing the need for hospital treatment and death due to influenza, pneumonia and invasive pneumococcal disease (IPD). Data on hospitalisation and mortality during 1 yr were obtained from the administrative database in Stockholm County Council. Vaccination was performed in 124,702 (48%) subjects; 72,107 had both vaccines, 29,346 only had the influenza vaccine and 23,249 only had the pneumococcal vaccine. Compared with the unvaccinated cohort, a lower incidence of hospitalisation for all endpoint diagnoses was seen in vaccinated persons. An additive effectiveness of vaccination was seen when both vaccines were given, with a reduction of hospital admissions for influenza (37%), pneumonia (29%) and IPD (44%). In-hospital mortality for pneumonia was significantly lower in those who received both vaccines, than in unvaccinated persons. To conclude, vaccination with influenza and pneumococcal vaccines together was effective in reducing the need for hospital admission for influenza and pneumonia. There was a strong indication that pneumococcal vaccination alone, was effective not only in the prevention of invasive pneumococcal disease, but also of pneumonia overall, although to a low degree.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065822     DOI: 10.1183/09031936.04.00063504

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  41 in total

Review 1.  [Immunosenescence and vaccinations in the elderly].

Authors:  Hans Joachim Hutt; Petra Bennerscheidt; Britta Thiel; Manuela Arand
Journal:  Med Klin (Munich)       Date:  2010-12-07

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

3.  [Pneumococcal vaccination in the over-65 population].

Authors:  Angel Vila Córcoles
Journal:  Aten Primaria       Date:  2007-06       Impact factor: 1.137

Review 4.  Inflammation and ageing.

Authors:  U Müller-Werdan
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

Review 5.  Vaccination greatly reduces disease, disability, death and inequity worldwide.

Authors:  F E Andre; R Booy; H L Bock; J Clemens; S K Datta; T J John; B W Lee; S Lolekha; H Peltola; T A Ruff; M Santosham; H J Schmitt
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

6.  Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial.

Authors:  Takaya Maruyama; Osamu Taguchi; Michael S Niederman; John Morser; Hiroyasu Kobayashi; Tetsu Kobayashi; Corina D'Alessandro-Gabazza; Sei Nakayama; Kimiaki Nishikubo; Takashi Noguchi; Yoshiyuki Takei; Esteban C Gabazza
Journal:  BMJ       Date:  2010-03-08

7.  Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study.

Authors:  Aba Mahamat; Jean-Pierre Daurès; Benoît de Wzieres
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

Review 8.  Vaccines for preventing pneumococcal infection in adults.

Authors:  Sarah Moberley; John Holden; David Paul Tatham; Ross M Andrews
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

Review 9.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto.

Authors:  Agron Plevneshi; Tomislav Svoboda; Irene Armstrong; Gregory J Tyrrell; Anna Miranda; Karen Green; Donald Low; Allison McGeer
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.